MASI - Masimo Corporation
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $1.43
|
Rev Est: $408.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$187.50
DETAILS
HIGH:
$200.00
LOW:
$180.00
MEDIAN:
$185.00
CONSENSUS:
$187.50
UPSIDE:
6.93%
Market Cap:
9.42B
Volume:
1,673,637
Avg Volume:
1,170,895
52 Week Range:
125.94-194.88
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.26
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
3,600
IPO Date:
2007-08-08
EPS (TTM):
-5.72
P/E Ratio:
-29.89
Revenue (TTM):
2.09B
Total Assets:
2.63B
Total Debt:
846.10M
Cash & Equiv:
177.60M
Rev Growth (5Y):
16.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-6.5%
ROCE:
-13.0%
Debt/Equity:
0.80
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $1.32 | $1.19 | +10.9% | $371.5M | $407.6M | -8.9% |
| 2025-08-05 | $1.33 | $1.23 | +8.1% | $370.9M | $369.0M | +0.5% |
| 2025-05-06 | $1.36 | $1.24 | +9.7% | $372.0M | $367.8M | +1.1% |
| 2025-02-25 | $1.80 | $1.42 | +26.8% | $600.7M | $593.3M | +1.2% |
| 2024-11-05 | $0.98 | $0.84 | +17.1% | $504.6M | $502.9M | +0.3% |
| 2024-08-06 | $0.86 | $0.77 | +11.7% | $496.3M | $493.6M | +0.6% |
| 2024-05-07 | $0.77 | $0.71 | +8.5% | $492.8M | $487.6M | +1.1% |
| 2024-02-27 | $1.25 | $0.95 | +31.6% | $548.9M | $545.7M | +0.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.09B | 2.05B | 2.04B | 1.24B | 1.14B | 937.84M | 858.29M | 790.25M | 712.90M | 630.11M | 586.64M | 547.25M |
| Net Income | (304.90M) | 81.50M | 143.50M | 229.60M | 240.30M | 196.22M | 193.54M | 131.62M | 300.67M | 83.30M | 72.52M | 58.38M |
| EPS | -5.72 | 1.54 | 2.68 | 4.16 | 4.39 | 3.67 | 3.45 | 2.42 | 6.28 | 1.62 | 1.33 | 1.03 |
| Total Assets | 2.63B | 3.04B | 3.21B | 1.89B | 1.71B | 1.40B | 1.15B | 905.44M | 820.52M | 601.74M | 565.01M | 438.66M |
| Total Debt | 846.10M | 970.00M | 1.03B | 32.70M | 34.35M | 20.49M | 0 | 0 | 71,000 | 185.15M | 125.22M | 1.69M |
| Cash & Equivalents | 177.60M | 163.00M | 202.90M | 745.30M | 641.45M | 567.69M | 552.49M | 315.30M | 305.97M | 132.32M | 134.45M | 95.47M |
| Operating Cash Flow | 196.40M | 94.10M | 29.40M | 264.60M | 211.10M | 221.64M | 239.53M | 58.11M | 416.84M | 114.21M | 95.46M | 54.32M |
| Free Cash Flow | 145.30M | 6.40M | (26.90M) | 229.70M | 131.20M | 149.15M | 216.84M | 11.35M | 392.49M | 59.62M | 17.05M | 41.30M |
| FCF per Share | 2.73 | 0.12 | -0.50 | 4.16 | 2.40 | 2.79 | 3.87 | 0.22 | 7.92 | 1.16 | 0.31 | 0.73 |
| Book Value | 1.05B | 1.36B | 1.34B | 1.55B | 1.41B | 1.17B | 969.07M | 724.02M | 560.24M | 275.42M | 306.00M | 326.47M |
| Cash & ST Investments | 177.60M | 163.00M | 202.90M | 745.30M | 641.45M | 687.69M | 552.49M | 315.30M | 305.97M | 132.32M | 134.45M | 95.47M |
| ROC Equity | -0.29 | 0.06 | 0.11 | 0.15 | 0.17 | 0.17 | 0.20 | 0.18 | 0.54 | 0.30 | 0.24 | 0.18 |